Table 1.
Cell line | Site of origin | Pathology | Molecular type (6) | Triple negative subtype (7) | BRCA1 status | TP53 status |
---|---|---|---|---|---|---|
MCF10A | Normal breast | Fibrocystic | Basal B | - | Wild type | Wild Type |
MCF7 | Pleural effusion | Adenocarcinoma | Luminal | - | Wild type | Wild Type |
T47D | Pleural effusion | Adenocarcinoma | Luminal | - | Wild type | Missense mutation |
MDA231 | Pleural effusion | Adenocarcinoma | Basal B | MSL | Wild type | Missense mutation |
MDA436 | Pleural effusion | Adenocarcinoma | Basal B | MSL | 5382insC | Nonsense mutation |
HCC1937 | Primary tumor | Infiltrating ductal carcinoma | Basal A | BL1 | 5396 + 1G>A | Nonsense mutation |
SUM149 | Primary tumor | Inflammatory breast carcinoma | Basal B | BL2 | 2288delT | Missense mutation |
SUM1315 | Skin metastasis | Infiltarting ductal carcinoma | Basal B | - | 185delAG | Missense mutation |
SUM1315-LXSN (SL) | Skin metastasis | Infiltarting ductal carcinoma | Basal B | - | 185delAG | Missense mutation |
SUM1315-BRCA1 (SB) | Skin metastasis | Infiltarting ductal carcinoma | Basal B | - | 185delAG + sauvage | Missense mutation |